Market Report
Asia report: Markets mixed as investors look to Fed
Markets in Asia finished in a mixed state on Tuesday, as investors closed their wallets ahead of this month’s Federal Reserve meeting in the United States.
Jones Lang LaSalle to buy HFF in $2bn deal
Jones Lang LaSalle has agreed to buy capital markets services provider HFF in a cash and stock deal worth about $2bn.
Europe midday: Stocks higher despite wary fund managers, Autos&Parts lead
The pace of buying on the Continent is picking up on the back of an unexpectedly strong reading on analyst sentiment towards Germany, helped by some positive headlines around Brexit and US-China trade talks.
London midday: Investors pick up unloved UK stocks despite Brexit uncertainty
London stocks are continuing to push higher, with Ocado leading the gains after a well-received trading statement and on the back of figures showing a drop in the rate of unemployment to its lowest level since 1975.
US pre-open: Stocks to rise as Fed kicks off policy meeting
US stocks looked set for a positive open on Tuesday as investors eyed the start of the Federal Reserve's two-day policy meeting.
Pelatro inks $500,000 revenue share deal with Kazakhstan-based telco
Multichannel marketing outfit Pelatro has inked a five-year revenue share deal with Kazakhstan-based telecommunications firm Tele2.
TP Icap profit drops as broker takes goodwill charge
TP Icap’s annual profit fell as the interdealer broker took a £65m charge on the reduced value of its assets.
Bloomsbury Publishing ends year in line with expectations
Bloomsbury Publishing issued a pre-close trading update for the 12 months ended 28 February on Tuesday, saying it expected results for the year to be in line with the board's expectations.
Roche gets FDA approval for Tecentriq chemotherapy combination
Roche announced on Tuesday that the US Food and Drug Administration (FDA) has approved ‘Tecentriq’ (atezolizumab), in combination with carboplatin and etoposide chemotherapy, for the initial treatment of adults with extensive-stage small cell lung cancer.
Focusrite revenues boosted by strong European showing
Music and audio products supplier Focusrite saw revenues move ahead in the first half of its trading year, driven by particularly strong sales in Europe.
Cambridge Cognition wins biggest digital health contract to date
Neuroscience technology company Cambridge Cognition Holdings announced a “significant” new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.
Amiad Water names Avishay Afriat as next CFO
Water treatment and filtration outfit Amiad has elevated Avishay Afriat to the role of chief financial officer and vice president of finance, effective immediately.
Oncimmune acquires Protagen Diagnostics in £4.11m deal
Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4. 11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.
Standard Life Aberdeen wins dispute against Lloyds
Standard Life Aberdeen said on Tuesday that a tribunal has ruled in its favour in respect of its investment mandate dispute with Lloyds Banking Group.
The Gym Group profits rise as new gyms opened, membership grows
The Gym Group reported a rise in full-year profits and revenue on Tuesday as it opened new gyms and increased its membership numbers.
Tilray revenues and losses widen in fourth quarter
Canadian marijuana outfit Tilray posted a wider than expected fourth-quarter loss even though revenues were bigger than forecast.
Kier appoints Andrew Davies as new CEO
Construction, services and property group Kier has appointed Andrew Davies as its new chief executive with effect from 15 April.
Bonmarche shares tumble as it issues another profit warning
Shares in Bonmarche tumbled on Tuesday after the womenswear retailer warned of a worse-than-expected full-year loss - its third profit warning in six months - as trading since the beginning of March has been "significantly" weaker.
HgCapital offloads investment in Foundry to Roper Technologies
HgCapital Trust announced the sale of high‑end visual effects and 3D design software developer Foundry to diversified technology company Roper Technologies on Tuesday, for £410m in cash.
Europe open: Stocks slip ahead of US Fed, Brexit in focus
Investors on the Continent appear to be pausing for breath ahead of the US central bank's policy announcement on Wednesday.